Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2017

Open Access 01-12-2017 | Short report

High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting

Authors: Abdul Rahman Zaidah, Nurul Izzah Mohammad, Siti Suraiya, Azian Harun

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2017

Login to get access

Abstract

Background

Infections by multidrug-resistant gram-negative bacteria (MDR-GNB) have been continuously growing and pose challenge to health institution globally. Carbapenem-resistant Enterobacteriacea (CRE) was identified as one of the MDR-GNB which has limited treatment options and higher mortality compared to those of sensitive strains. We report an increased burden of CRE fecal carriage at a hospital in the North-eastern region of Malaysia.

Methods

A retrospective descriptive study from August 2013 to December 2015 was conducted in the Medical Microbiology & Parasitology laboratory of Hospital Universiti Sains Malaysia, which is a tertiary teaching hospital with more than 700 beds. This hospital treats patients with various medical and surgical conditions. Suspected CRE from any clinical specimens received by the laboratory was identified and confirmed using standard protocols. Polymerase chain reaction (PCR) assay was performed to determine the genotype.

Results

Altogether, 8306 Enterobacteriaceae was isolated from various clinical specimens during the study period and 477/8306 (5.74%) were CRE. Majority of the isolated CRE were Klebsiella [408/477, (85.5%)], of which Klebsiella pneumoniae was the predominant species, 388/408 (95%). CRE were mainly isolated from rectal swab (screening), 235/477 (49.3%); urine, 76/477 (15.9%); blood, 46/477 (9.6%) and about 7.1% from tracheal aspirate. One hundred and thirty-six isolates were subjected to genotype determination and., 112/136 (82.4%) showed positive detection of New Delhi metallo-β-lactamase 1 (NDM-1) gene (bla NDM1).

Conclusion

The study noted a high numbers of CRE isolated especially from rectal swabs. Active screening results in significant cost pressures and therefore should be revisited and revised, especially in low resource settings.
Literature
1.
go back to reference Duin DV, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2016;11:1–10.CrossRef Duin DV, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2016;11:1–10.CrossRef
2.
go back to reference Xu Y, Gu B, Huang M, et al. Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000–2012 in Asia. J Thorac Dis. 2015;7(3):376–85.PubMedPubMedCentral Xu Y, Gu B, Huang M, et al. Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000–2012 in Asia. J Thorac Dis. 2015;7(3):376–85.PubMedPubMedCentral
3.
go back to reference Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009–2010. Infect Control Hosp Epidemiol. 2013;34(1):1–14. 2013.CrossRefPubMed Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009–2010. Infect Control Hosp Epidemiol. 2013;34(1):1–14. 2013.CrossRefPubMed
4.
go back to reference Lyman M, Walters M, Lonsway D, Rasheed K, Limbago B, Kallen A. Notes from the field: carbapenem-resistant Enterobacteriaceae producing OXA-48-like carbapenemases—United States, 2010–2015. Morb Mortal Wkly Rep. 2015;64(47):1315–6.CrossRef Lyman M, Walters M, Lonsway D, Rasheed K, Limbago B, Kallen A. Notes from the field: carbapenem-resistant Enterobacteriaceae producing OXA-48-like carbapenemases—United States, 2010–2015. Morb Mortal Wkly Rep. 2015;64(47):1315–6.CrossRef
5.
go back to reference Hamzan NI, Yean CY, Rahman RA, Hasan H, Rahman ZA. Detection of blaIMP4 and blaNDM1 harboring Klebsiella pneumoniae isolates in a university hospital in Malaysia. Emerg Health Threats J. 2015;8:26011.PubMed Hamzan NI, Yean CY, Rahman RA, Hasan H, Rahman ZA. Detection of blaIMP4 and blaNDM1 harboring Klebsiella pneumoniae isolates in a university hospital in Malaysia. Emerg Health Threats J. 2015;8:26011.PubMed
6.
go back to reference Zainol Abidin NZ, Sulong A, Alfizah H, Muttaqillah NA, Ding CH. Molecular detection of the New Delhi metallo-β-lactamase-1 gene in Enterobacteriaceae isolates in a tertiary medical centre. Malays J Pathol. 2015;37(3):227–32.PubMed Zainol Abidin NZ, Sulong A, Alfizah H, Muttaqillah NA, Ding CH. Molecular detection of the New Delhi metallo-β-lactamase-1 gene in Enterobacteriaceae isolates in a tertiary medical centre. Malays J Pathol. 2015;37(3):227–32.PubMed
7.
go back to reference Siegel JD, Rhinehart E, Jackson M, Chiarello L. Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165–93. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165–93.
8.
go back to reference CDC. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) November 2015 update — CRE toolkit. 2015. CDC. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) November 2015 update — CRE toolkit. 2015.
9.
go back to reference Wilson APR, Livermore DM, Otter JA, et al. Prevention and control of multi-drug-resistant gram-negative bacteria: recommendations from a Joint Working Party. J Hosp Infect. 2016;92 Suppl 1;S1–44. Wilson APR, Livermore DM, Otter JA, et al. Prevention and control of multi-drug-resistant gram-negative bacteria: recommendations from a Joint Working Party. J Hosp Infect. 2016;92 Suppl 1;S1–44.
10.
go back to reference Birgand G, Leroy C, Nerome S, et al. Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France. BMJ Open. 2016;6(1):e009029.CrossRefPubMedPubMedCentral Birgand G, Leroy C, Nerome S, et al. Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France. BMJ Open. 2016;6(1):e009029.CrossRefPubMedPubMedCentral
11.
go back to reference Neidell MJ, Cohen B, Furuya Y, Hill J, Jeon CY, Glied S, Larson EL. Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms. Clin Infect Dis. 2012;55(6):807–15.CrossRefPubMedPubMedCentral Neidell MJ, Cohen B, Furuya Y, Hill J, Jeon CY, Glied S, Larson EL. Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms. Clin Infect Dis. 2012;55(6):807–15.CrossRefPubMedPubMedCentral
12.
go back to reference Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.CrossRefPubMed Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.CrossRefPubMed
13.
go back to reference Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9:228–36.CrossRefPubMed Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9:228–36.CrossRefPubMed
14.
go back to reference Molton JS, Tambyah PA, Ang BSP, Ling ML, Fisher DA. The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin Infect Dis. 2013;56(9):1310–8.CrossRefPubMed Molton JS, Tambyah PA, Ang BSP, Ling ML, Fisher DA. The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin Infect Dis. 2013;56(9):1310–8.CrossRefPubMed
15.
go back to reference Luci C, Marines Dalla Valle M, Itacy S, Jacyr P, Ana Cristina G, Claudia Vallone S, Thiago Zinsly Sampaio C, Patricia Faria S, Alexandre Rodrigues M. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC Infect Dis. 2013;13:80.CrossRef Luci C, Marines Dalla Valle M, Itacy S, Jacyr P, Ana Cristina G, Claudia Vallone S, Thiago Zinsly Sampaio C, Patricia Faria S, Alexandre Rodrigues M. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC Infect Dis. 2013;13:80.CrossRef
16.
go back to reference Borer A, Saidel-Odes L, Riesenberg K, Eskira S, Peled N, Nativ R, Schlaeffer F, Sherf M. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol. 2009;30(10):972–6. doi:10.1086/605922.CrossRefPubMed Borer A, Saidel-Odes L, Riesenberg K, Eskira S, Peled N, Nativ R, Schlaeffer F, Sherf M. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol. 2009;30(10):972–6. doi:10.​1086/​605922.CrossRefPubMed
17.
go back to reference Suwantarat N, Carroll KC. Epidemiology and molecular characterization of multidrug-resistant gram-negative bacteria in Southeast Asia. Antimicrob Resist Infect Control. 2016;4(5):15. Suwantarat N, Carroll KC. Epidemiology and molecular characterization of multidrug-resistant gram-negative bacteria in Southeast Asia. Antimicrob Resist Infect Control. 2016;4(5):15.
18.
go back to reference Teo JWP, Tan P, La MV, et al. Surveillance trends of carbapenem-resistant Enterobacteriaceae from Singapore, 2010–2013. J Glob Antimicrob Resist. 2014;2(2):99–102.CrossRefPubMed Teo JWP, Tan P, La MV, et al. Surveillance trends of carbapenem-resistant Enterobacteriaceae from Singapore, 2010–2013. J Glob Antimicrob Resist. 2014;2(2):99–102.CrossRefPubMed
19.
go back to reference Western Australian Multi-Resistant Organism (WAMRO) Expert Advisory Group. Infection prevention and control of carbapenem-resistant Enterobacteriaceae (CRE) in western Australian healthcare facilities (version 1). 2012. Western Australian Multi-Resistant Organism (WAMRO) Expert Advisory Group. Infection prevention and control of carbapenem-resistant Enterobacteriaceae (CRE) in western Australian healthcare facilities (version 1). 2012.
20.
go back to reference Public Health England. Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae. 2013. Public Health England. Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae. 2013.
21.
go back to reference Gunther MF, Frank U, Mischnik A. Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measures. J Hosp Infect. 2016;93:191–6.CrossRefPubMed Gunther MF, Frank U, Mischnik A. Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measures. J Hosp Infect. 2016;93:191–6.CrossRefPubMed
22.
go back to reference Singh K, Mangold KA, Wyant K, et al. Rectal screening for Klebsiella pneumoniae carbapenemases: comparison of real-time PCR and culture using two selective screening agar plates. J Clin Microbiol. 2012;50(8):2596–600.CrossRefPubMedPubMedCentral Singh K, Mangold KA, Wyant K, et al. Rectal screening for Klebsiella pneumoniae carbapenemases: comparison of real-time PCR and culture using two selective screening agar plates. J Clin Microbiol. 2012;50(8):2596–600.CrossRefPubMedPubMedCentral
23.
go back to reference Lowman W, Marais M, Ahmed K, Marcus L. Routine active surveillance for carbapenemase-producing Enterobacteriaceae from rectal swabs: diagnostic implications of multiplex polymerase chain reaction. J Hosp Infect. 2014;88:66–71.CrossRefPubMed Lowman W, Marais M, Ahmed K, Marcus L. Routine active surveillance for carbapenemase-producing Enterobacteriaceae from rectal swabs: diagnostic implications of multiplex polymerase chain reaction. J Hosp Infect. 2014;88:66–71.CrossRefPubMed
24.
go back to reference Huskins WC, Huckabee CM, O’Grady NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011;364(15):1407–18.CrossRefPubMedPubMedCentral Huskins WC, Huckabee CM, O’Grady NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011;364(15):1407–18.CrossRefPubMedPubMedCentral
25.
go back to reference Schechner V, Kotlovsky T, Kazma M, et al. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect. 2013;19(5):451–6. Schechner V, Kotlovsky T, Kazma M, et al. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect. 2013;19(5):451–6.
26.
go back to reference Pogorzelska M, Stone PW, Larson EL. Wide variation in adoption of screening and infection control interventions for multidrug-resistant organisms: a national study. Am J Infect Control. 2012;40(8):696–700.CrossRefPubMedPubMedCentral Pogorzelska M, Stone PW, Larson EL. Wide variation in adoption of screening and infection control interventions for multidrug-resistant organisms: a national study. Am J Infect Control. 2012;40(8):696–700.CrossRefPubMedPubMedCentral
Metadata
Title
High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting
Authors
Abdul Rahman Zaidah
Nurul Izzah Mohammad
Siti Suraiya
Azian Harun
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2017
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-017-0200-5

Other articles of this Issue 1/2017

Antimicrobial Resistance & Infection Control 1/2017 Go to the issue